CLOV vs PFE
Clover Health Investments Corp (CLOV) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CLOV currently screens at market cap $1.55B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CLOV and PFE stock pages for the full models.
Not investment advice.